Identification of Novel Therapeutic Targets for Hypertension
Zhiwei Zheng(Beijing University of Chinese Medicine), Sen Li(University of Shanghai for Science and Technology), Chunyan Hou(Georgetown University), Yining Ding(Beijing University of Chinese Medicine), Shuling Xu(Beijing University of Chinese Medicine), Menghua Liu(Beijing University of Chinese Medicine), Rumeng Chen(Beijing University of Chinese Medicine)
Cited by 5
Related Papers
Dingxin Recipe IV attenuates atherosclerosis by regulating lipid metabolism through LXR-α/SREBP1 pathway and modulating the gut microbiota in ApoE-/- mice fed with HFD
|Journal of Ethnopharmacology|2020|87
Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study
|Frontiers in Endocrinology|2024|69
Dissecting causal associations of type 2 diabetes with 111 types of ocular conditions: a Mendelian randomization study
|Frontiers in Endocrinology|2023|36
Environmental endocrine disruptor-induced mitochondrial dysfunction: a potential mechanism underlying diabetes and its complications
|Frontiers in Endocrinology|2024|36
Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis
|Frontiers in Endocrinology|2024|29